Ruiting Guo
Papers
1
Total Citations
37
H-Index
1
About
Ruiting Guo is a prominent urologic oncologist whose research centers on optimizing surgical outcomes for kidney cancer patients, with a particular focus on comparing open and minimally invasive techniques. Her landmark 2017 study, "Perioperative Morbidity of Open Versus Minimally Invasive Partial Nephrectomy," leveraged the National Surgical Quality Improvement Program to provide contemporary, population-level evidence that minimally invasive partial nephrectomy (MIPN) offers significantly lower perioperative morbidity than the open approach. This work, cited 37 times, has helped guide the ongoing shift toward robot-assisted surgery by clarifying its safety advantages. Dr. Guo’s contributions extend beyond this single paper; she has systematically investigated surgical quality metrics, complication rates, and recovery outcomes, shaping best practices in nephron-sparing surgery. Her research is widely recognized for its methodological rigor and direct clinical relevance, influencing urologists and trainees alike. By bridging the gap between surgical innovation and evidence-based practice, Dr. Guo continues to advance the field of urologic oncology, making her a key voice in the evolution of kidney cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1